Delivery Order SPE2DB22D2108-SPE2DB24FU3LE

Award Date 3/12/24
Potential Completion Date 3/13/24
Potential Value $42K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $10,258.30 for the supply of Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of May 11, 2023. The prime contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order with a ceiling value of $6,931.42 for the supply of Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 29, 2022. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,128.78 firm fixed-price delivery order is for the pharmaceutical product Eliquis 5 mg tablets. The award has an ultimate completion date of February 29, 2024 and was made on February 28, 2024. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $10,041.31 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Eliquis 5 mg tablets and has an ultimate completion date of January 21, 2022. This award is under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $20,572.44 and an ultimate completion date of May 3, 2023. This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued up to $999,999,999 and running through November 2026. The IDC serves...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $12,252.77 for the supply of ELIQUIS 5 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Eliquis 5 mg tablets to the U.S. government. The $3,969.61 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $6,993.30 for the supply of Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 5, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Eliquis 5 mg tablet 60s. The $8,375.03 Firm Fixed Price Delivery Order has a completion date of January 24, 2024 and was awarded on January 23, 2024. This award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $25,264.04 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Cencora, Inc. to deliver a...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB24FU3LE
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $41,960.18 from the Defense Logistics Agency (DLA) for the pharmaceutical product Eliquis 5 mg tablet 60s. The award has an ultimate completion date of March 13, 2024 and utilizes a Firm Fixed Price pricing type. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific Delivery Order does not have a set-aside designation, indicating open competition.

Generated 5/14/25, 10:30 AM